Cardiovascular Toxicology delves into the intricate study of the detrimental effects of various compounds on the cardiovascular system. This specialized field integrates principles from pharmacology, toxicology, and cardiology to unravel the impact of drugs, chemicals, and environmental factors on the heart and blood vessels. Experts in cardiovascular toxicology strive to uncover and evaluate potential risks associated with exposure to specific substances, especially those prevalent in medications, industrial processes, or everyday surroundings. By delving into the underlying mechanisms through which these agents influence cardiovascular function, researchers contribute essential knowledge to the development of safer pharmaceuticals, environmental policies, and occupational safety standards. The overarching aim of cardiovascular toxicology is to deepen our comprehension of cardiovascular health, diminish potential hazards, and advance preventive measures against cardiovascular-related diseases.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt